USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Multitargeted Kinase Inhibitors, BRAF
Tovorafenib
D12291 Tovorafenib (USAN/INN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
BRAF* [HSA_VAR:673v1673v2]
D12291 Tovorafenib (USAN/INN) <US>
RAF1
D12291 Tovorafenib (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12291
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12291
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D12291